Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
AssigneeRoche Diagnostics GmbH
InventorsPaul Lehmann, Jürgen Feuerstein, Michael Harold Town
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical combination preparation comprising an erythropoietin preparation that provides active erythropoietin and at least one modified haemoglobin wherein the erythropoietin preparation and modified haemoglobin can be present in separate forms of administration or in a single form of administration. The pharmaceutical combination preparations of the present invention can be used to treat manifest anemias with or without iron utilization disorders.
Claims3
A method of treating manifest anemias in a patient comprising administering to the patient once weekly a pharmaceutical combination preparation containing an erythropoietin preparation that provides active erythropoietin in an amount of from about 3000 U to about 7000 U, and from about 50 ml to about 100 ml of at least one modified hemoglobin so as to correspond to from about 100 mg to about 200 mg of Fe2+.
Dependencies are inferred from the claim text.